Review of combination of peritoneal dialysis and hemodialysis as a modality of treatment for end-stage renal disease

Therapeutic Apheresis and Dialysis

Volumn 8, Issue 1, 2004, Pages 56-61

  Fukui, H ^b   Hara, S ^b   Hashimoto, Yasuki ^a   Horiuchi, T ^b   Ikezoe, M ^b   Itami, N ^b   Kawabe, M ^b   Kawanishi, H ^b   Kimura, Y ^b   Nakamoto, H ^b   Nakayama, M ^b   Ono, M ^b   Ota, K ^b   Shinoda, T ^b   Suga, T ^b   Ueda, T ^b   Fujishima, M ^b   Maeba, T ^b   Yamashita, A ^b   Yoshino, Y ^b   Watanabe, S ^b   Watanabe, T ^b   more..

^a Ichinomiya Municipal Hospital   (Japan)

^b NONE

Author keywords

Complementary dialysis therapy; Peritoneal dialysis and hemodialysis combination therapy; Residual renal function

Indexed keywords

WATER;

COMPLEMENTARY DIALYSIS THERAPY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; COST CONTROL; DAILY LIFE ACTIVITY; DIALYSIS; HEALTH CARE COST; HEALTH ECONOMICS; HEMODIALYSIS; HUMAN; KIDNEY CLEARANCE; KIDNEY FAILURE; KIDNEY FUNCTION; PATIENT ATTITUDE; PATIENT SATISFACTION; PERITONEAL DIALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SOLUTE; ULTRAFILTRATION; UREMIA; CHRONIC KIDNEY FAILURE; ECONOMICS; METHODOLOGY; MULTIMODALITY CANCER THERAPY; RENAL REPLACEMENT THERAPY; STANDARD;

COMBINED MODALITY THERAPY; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; QUALITY OF LIFE; RENAL DIALYSIS;

EID: 3042784914     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-0968.2004.00107.x     Document Type: Review

References (18)

1. Oreopoulos DG. The optimization of continuous ambulatory pwritoneal dialysis. Kidney Int 1999;55:1131-49.
2. Hashimoto Y, Matsubara T. The utility of 'Quantum', the nocturnal bag exchange device, as a tool for adequacy. CTPD 2001;19:31-4 (in Japanese).
3. Ota K. Why is PD + HD combination therapy necessary? Touseki Care 2001;7:18-19 (in Japanese).
4. Arizono K, Matsuoka K, Miyamoto T et al. Examination of the utility for PD + HD combination therapy. Jin to Touseki 1999;47:65-9 (in Japanese).
5. Arizono K, Fukui H, PD + HD Combination study Group. The real state of PD + HD combination therapy operation in Japan. Jin to Touseki 2001;51:181-4 (in Japanese).
6. Fukui H, Arizono K, Kimura Y et al. Indication and application of PD + HD combination therapy from a survey of Japanese experts. Jin to Touseki 2002;53:20-4 (in Japanese).
7. Kawanishi H, Moriishi M, Katsutani S, Sakikudo E, Tsuchiya S. Hemodialysis together with peritoneal dialysis is one of the simplest ways to maintain adequacy in continuous ambulatory peritoneal dialysis. Adv Perit Dial 1999;15:127-31.
8. Casino FG, Lopez T. The equivalent renal urea clearance: a new parameter to assess dialysis dose. Nephrol Dial Transplant 1996;11:1574-81.
9. Kikuchi H, Taru Y, Hibino T et al. PD + HD combination therapy as a treatment for adequacy of dialysis. In: Ota K, ed. Peritoneal Dialysis '98. Tokyo: Tokyo Igakusha, 1998;57-60 (in Japanese).
10. Yamashita A. The basis of blood purification blood purification that use PD together with HD (I). Rinsho Touseki 2000;16:1817-21 (in Japanese).
11. Arizono K, Matsuoka K, Miyamoto T et al. An experiment of HD combination therapy for CAPD. In: Ota K, ed. Peritoneal Dialysis '98. Tokyo: Tokyo Igakusha, 1998;52-6 (in Japanese).
12. Arizono K, Nomura T, Matsuoka K et al. The utility of intermittent peritoneal rest against ultrafiltration failure during introduction stage in CAPD. Jin to Touseki 2000;49:122-6 (in Japanese).
13. Kawahara K, Minaguchi J, Amano H et al. Alteration of peritoneal functionduring peritoneal resting period in PD patients. In: Ota K, ed. Peritoneal Dialysis '98. Tokyo: Tokyo Igakusha, 1998;255-6 (in Japanese).
14. Yamamoto T, Izumodani T, Kim M. The utility of HD combination therapy from a viewpoint of mesothelial cells in CAPD effluent. In: Ota K, ed. Peritoneal Dialysis 2002. Tokyo: Tokyo Igakusha, 2003.
15. Yamamoto T, Kim M. Morphologies of Mesothelial Cells in CAPD effluent and their clinical significances. J Jap Soc Dial Ther 1997;30:1225-31 (in Japanese).
16. Hashimoto Y, Matsubara T. Combined peritoneal dialysis and hemodialysis therapy improves quality of life in end-stage renal disease patients. Adv Perit Dial 2000;16:108-12.
17. Laupacis A, Muirhead N, Keown P, Wong C. A disease specific questionnaire for assessing quality of life in patients on hemodialysis. Nephron 1992;60:302-6.
18. Yamashita A. The basis of Blood Purification Blood Purification that use HD together with PD (II). Rinsho Touseki 2000;16:1925-9 (in Japanese).